Last updated: January 15, 2021
Sponsor: Nantes University Hospital
Overall Status: Terminated
Phase
N/A
Condition
Asthma
Treatment
N/AClinical Study ID
NCT02911220
RC15_0354
2016-A00922-49
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- index case:
- Major
- Lack of respiratory disease documented in the medical record other than asthma
- Severe Asthma by definition ATS / ERS 2014:
- Treatment with high doses of CI and beta2 agonists for long-acting (B2LDA) or antileukotriene or theophylline during the previous year or oral corticosteroids (CO) morethan 50% from the previous year to prevent loss of control asthma.
- Asthma "uncontrolled" (at least 1 criteria):
- ACT <20 and / or ACQ> 1.5 (Asthma Control Test)
- 2 courses or more CO in the previous year
- 1 hospitalization for asthma in the previous year
- FEV <80% predicted despite bronchodilators.
- Examination or medical record to find at least one member of the geneticallynon-atopic asthma associated family
- Prick negative tests for common allergens, questionnaire seeking negative atopy (SFARLove) Phadiatop or negative diagnosis of non-atopic asthma confirmed by theadjudication committee
- informed and written consent of the patient to participate in the study
- Affiliated to a social security scheme
Exclusion
Exclusion Criteria:
- Pregnant women
- Minors
- Known associated respiratory pathologies (COPD, bronchial dilatation, diffuseinfiltrating pneumopathy)
- Major Trust
- Subject having demonstrated the inability or refusal to sign an informed consent Relatives' patients:
- Major
- Related to the 1st and 2nd level of the index case or another member with family
- Related with or without a asthma (atopic or non-atopic)
- Informed and written consent of the patient to participate in the study Affiliated toa social security scheme Exclusion Criteria:
- Pregnant women
- Minors
- Major Trust
- Subject having demonstrated the inability or refusal to sign an informed consent
Study Design
Total Participants: 2
Study Start date:
February 26, 2020
Estimated Completion Date:
February 26, 2020
Study Description
Connect with a study center
CHU de Nantes - Service de Pneumologie - HGRL
Nantes, 44000
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.